Group Education Program for Depression
Treatments studied
Part of Mental health clinical trials.
This trial tests a group education program (psychoeducation) for people with moderate to severe major depression. It’s designed to help you learn skills to manage your depression alongside medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with major depressive disorder by a doctor.
- Your depression is moderate to severe (not mild or extremely severe).
- You are not currently in another type of talk therapy for depression.
- You are not at risk of suicide or having thoughts of harming yourself.
- You do not have other serious mental health conditions like bipolar disorder or schizophrenia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using sedation (medicine to help you relax) along with guided education can help treat depression. It may provide a new treatment option for people with moderate to severe depression.
This trial compares two types of group therapy for major depression: one that focuses on changing your expectations about the future, and another that helps you reconnect with rewarding activities. The goal is to see which approach works better for reducing depression symptoms.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
This study tests a remote education program (tele-education) for people with moderate depression who recently started an antidepressant. The program helps you learn skills to manage your mood, and you can take part from home.
This study tests whether a physical activity program can help adults whose depression hasn’t improved after trying at least two antidepressants. If you’re sedentary, between 18 and 65, and have treatment-resistant depression, this program might offer a new way to feel better through exercise.
This Phase 2 trial tests whether an NMDA-targeted treatment can improve symptoms of major depressive disorder (MDD). You may be able to join if your depression diagnosis and symptom score fit, and you meet several safety and study-following requirements.
Hear when a new Major Depressive Disorder (MDD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.